Accelerated Progression of Hepatocellular Carcinoma during Immunosuppressive Therapy with Abatacept for Rheumatoid Arthritis

Abatacept, a cytotoxic T lymphocyte antigen-4 immunoglobulin recombinant fusion protein, is an immunosuppressive agent indicated for rheumatoid arthritis. Although no significant increase in malignancy has been reported in abatacept-treated patients, whether or not abatacept accelerates tumor progre...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshiji, Satoshi, Takahashi, Ken, Sawada, Kenji, Mishima, Masako, Eso, Yuji, Morita, Masahiro, Takai, Atsushi, Marusawa, Hiroyuki, Ueda, Yoshihide, Mimori, Tsuneyo, Seno, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367098/
https://www.ncbi.nlm.nih.gov/pubmed/30146566
http://dx.doi.org/10.2169/internalmedicine.0843-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367098/
https://www.ncbi.nlm.nih.gov/pubmed/30146566
http://dx.doi.org/10.2169/internalmedicine.0843-18

Ejemplares similares